Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
J Cutan Pathol ; 50(7): 629-631, 2023 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-36661383

RESUMEN

Sporotrichosis is a subacute-to-chronic infection caused by Sporothrix species, a dimorphic fungus. Virulence varies by Sporothrix species and presentation can be region dependent. The patient had a history of immunosuppression as a result of a kidney transplant, and presented with a high disease burden on histopathological examination, but responded well to itraconazole. The case suggests considering Sporothrix speciation in immunocompromised patients to best determine treatment modality and duration.


Asunto(s)
Criptococosis , Trasplante de Riñón , Sporothrix , Esporotricosis , Humanos , Itraconazol , Esporotricosis/diagnóstico , Esporotricosis/microbiología , Esporotricosis/patología , Antifúngicos/uso terapéutico
5.
Arch Dermatol Res ; 315(10): 2877-2881, 2023 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-37682336

RESUMEN

Patients with alopecia areata (AA) may experience episodic hair loss that follows seasonal patterns. To assess associations between seasonal variation, climate factors, and AA flare frequency in pediatric AA patients, we performed a retrospective chart review of 123 pediatric AA patients at Brown Dermatology (Providence, Rhode Island) who experienced hair loss between January 2017 and December 2019. We assessed association of seasonal variation with monthly occurrence of AA flares. We then assessed association between climate variables and monthly AA hair loss frequency using Spearman rank correlation analyses. We conducted stratified analyses in patients with and without history of atopy. The greatest proportion of hair loss episodes occurred in winter (28.1%), followed by autumn (26.3%), spring (23.8%), and summer (21.7%). We found significant correlations between AA hair loss frequency and air pressure (R = 0.61) and hours of sunlight (R = - 0.60). These correlations remained significant among patients with no history of atopic disease but were not significant among those with history of atopy. Limitations include small sample size. This regional analysis supports the role of climate in AA hair loss episodes through assessment of seasonal occurrences and identification of correlations between climate characteristics and AA flare frequency.


Asunto(s)
Alopecia Areata , Humanos , Niño , Alopecia Areata/epidemiología , Estaciones del Año , Estudios Retrospectivos , Rhode Island/epidemiología , Alopecia
6.
BMJ Case Rep ; 14(2)2021 02 26.
Artículo en Inglés | MEDLINE | ID: mdl-33637513

RESUMEN

A severe case of COVID-19 was observed in an otherwise healthy 28-year-old man who had taken oxandrolone 40 mg/day as an anabolic steroid. The patient had been taking oxandrolone for enhanced bodybuilding 30 days prior to presenting to an outpatient clinic with COVID-19 symptoms. The patient reported that his symptoms have rapidly worsened over the course of 4 days prior to presenting at the clinic. As part of an experimental antiandrogen treatment for hyperandrogenic men suffering from COVID-19, he was administered a single 600 mg dose of the novel antiandrogen proxalutamide. Twenty-four hours after administration of this dose, marked improvement of symptoms and markers of disease severity were observed. To our knowledge, this is the first case that potentially links anabolic steroid use to COVID-19 disease severity.


Asunto(s)
Anabolizantes/efectos adversos , Antagonistas de Andrógenos/administración & dosificación , Tratamiento Farmacológico de COVID-19 , Oxandrolona/efectos adversos , Oxazoles/administración & dosificación , Tiohidantoínas/administración & dosificación , Adulto , Anabolizantes/administración & dosificación , Progresión de la Enfermedad , Humanos , Masculino , Oxandrolona/administración & dosificación , Sustancias para Mejorar el Rendimiento/efectos adversos , SARS-CoV-2 , Índice de Severidad de la Enfermedad
7.
Adv Biol Regul ; 75: 100668, 2020 01.
Artículo en Inglés | MEDLINE | ID: mdl-31653550

RESUMEN

Because sunlight is essential for human survival, we have developed complex mechanisms for detecting and responding to light stimuli. The eyes and skin are major organs for sensing light and express several light-sensitive opsin receptors. These opsins mediate cellular responses to spectrally-distinct wavelengths of visible and ultraviolet light. How the eyes mediate visual phototransduction is well understood, but less is known about how the skin detects light. Both human and murine skin express a wide array of opsins, with one of the most highly expressed being the functionally elusive opsin 3 (OPN3). In this review we explore light reception, opsin expression and signaling in skin cells; we compile data elucidating potential functions for human OPN3 in skin, with emphasis on recent studies investigating OPN3 regulation of melanin within epidermal melanocytes.


Asunto(s)
Epidermis/metabolismo , Regulación de la Expresión Génica/fisiología , Melanocitos/metabolismo , Opsinas de Bastones/biosíntesis , Transducción de Señal/fisiología , Animales , Humanos , Ratones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA